Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05880667 · ClinicalTrials.gov registry record · Phase 1
Adaptive Radiation for Abdominopelvic Metastases
A Phase 1 study of Neoplasm - Soft Tissue Pelvis Malignant Secondary and Malignant Neoplasm of Stomach, sponsored by Fox Chase Cancer Center.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05880667 is a Phase 1 study of Neoplasm - Soft Tissue Pelvis Malignant Secondary and Malignant Neoplasm of Stomach that is actively recruiting participants, run by Fox Chase Cancer Center. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05880667, a Phase 1 study of Neoplasm - Soft Tissue Pelvis Malignant Secondary and Malignant Neoplasm of Stomach, is actively recruiting participants, sponsored by Fox Chase Cancer Center.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Single arm Phase I trial of adaptive stereotactic body radiation (SBRT) for abdominopelvic metastases. Adaptive SBRT will allow for escalation of the prescription dose and target coverage while maintaining grade 3+ toxicity no greater than 10%. Subjects with metastatic cancer to the abdomen or pelvis requiring local control or palliation will be enrolled.
Conditions Studied
Interventions
- RADIATION Adaptive Stereotactic Body Radiation
Study Locations (1)
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2029-06-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05880667
The ClinicalTrials.gov registry entry for NCT05880667 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Neoplasm - Soft Tissue Pelvis Malignant Secondary appearing as the primary indexed condition, and to 1 intervention - of which Adaptive Stereotactic Body Radiation is the first listed.
NCT05880667 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05880667 about?
NCT05880667 is a clinical study titled "Adaptive Radiation for Abdominopelvic Metastases". Single arm Phase I trial of adaptive stereotactic body radiation (SBRT) for abdominopelvic metastases. Adaptive SBRT will allow for escalation of the prescription dose and target coverage while maintaining grade 3+ toxicity no greater than 10%. Subjects with metastatic cancer to the abdomen or pelvi...
What is the current status of trial NCT05880667?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2023-08-01. Estimated completion is 2029-06-01.
What conditions does trial NCT05880667 study?
This clinical trial studies the following conditions: Neoplasm - Soft Tissue Pelvis Malignant Secondary, Malignant Neoplasm of Stomach.
What interventions are being tested in trial NCT05880667?
The interventions under investigation include: Adaptive Stereotactic Body Radiation (RADIATION).
Who is sponsoring clinical trial NCT05880667?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05880667 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Neoplasm - Soft Tissue Pelvis Malignant Secondary
All registered trials for this condition
Malignant Neoplasm of Stomach
All registered trials for this condition
Pennsylvania
All trials with a study site in Pennsylvania
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.